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Summary 
Methods based on nanotechnologies play a growing role in biomedical research. Quantum 
dots (QDs) are a group of engineered fluorescent nanoparticles suited for advanced 
imaging applications. The substitution of the particle’s surface with defined molecular 
structures could enable the adoption as targeted contrast agents or therapeutic devices for 
a variety of clinical approaches. However, important aspects such as the basic surface-
dependent behavior of non-targeted QDs in the organism and arising health effects upon 
systemic administration remain incompletely understood. Acute inflammatory effects for 
instance are often initiated on the microcirculatory level and are probably relevant for 
cardiovascular pathologies observed in epidemiologic and experimental studies of certain 
nanoparticles. Most in vitro studies show that the surface structures of QDs and other 
nanoparticles seem to be predominantly accountable for different cytotoxic effects and a 
variable potential to liberate proinflammatory cytokines. Currently, no systematic in vivo 
studies have addressed surface-dependent interactions of QDs on the level of the 
microcirculation and assessed the resulting impact on biokinetics as well as on 
proinflammatory parameters. Thus, this thesis aimed to i) analyze the incidence of QD-
surface-dependent acute microvascular interactions and their influence on key biokinetic 
parameters and ii) investigate acute immunomodulatory effects on the multistep process 
of leukocyte recruitment in vivo. For this, three types of commercially available QDs with 
different surface modifications: carboxyl-QDs, amine- and polyethylene glycol-QDs 
(amine-QDs) and polyethylene glycol-QDs (PEG-QDs) were used. The physicochemical 
characterization was done by dynamic light scattering (DLS) analysis and microscale 
thermophoresis. In a first set of experiments, circulating half-lives, tissue distribution in 
different organs, and hepatic as well as renal clearance were measured. Ex vivo analysis 
of QD tissue distribution was performed on selected tissue samples via transmission 
electron microscopy (TEM) and two-photon microscopy. By combining reflected-light 
oblique transillumination (RLOT) and fluorescence in vivo microscopy of the murine M. 
cremaster, interactions of QDs with components of the microcirculation as well as 
leukocyte migration parameters were visualized and quantified. The extreme short 
circulating half-life of anionic carboxyl-QDs was related to pronounced clearance by the 
mononuclear phagocyte system. Beyond this, further investigations showed, for the first 
time, that the continuous capillary endothelium of skeletal and heart muscle tissue has the 
capacity to directly extract carboxyl-QDs from the circulation by means of caveolae-
mediated endocytosis. Carboxyl-QDs were also taken up by perivascular macrophages in 
the surgically exposed but not in the native M. cremaster and led to a significant increase 
of adherent and (subsequently) transmigrated leukocytes in this model. Further 
experiments provided evidence for a probable involvement of mast cells in the 
intercellular adhesion molecule-1 (ICAM-1)- and endothelial (E)-selectinmediated 
modulation of leukocyte recruitment. This process is most likely initiated by the 
endocytosis of carboxyl-QDs through activated perivascular macrophages. The primary 
activation of tissue-resident perivascular macrophages seems to be the consequence of 
tissue damage related to the surgical preparation of the cremaster muscle. This is 
supposedly a prerequisite for the endocytosis of carboxyl-QDs whereupon endothelial and 
mast cells seem to be secondarily activated in a paracrine fashion that then leads to an 
increase in leukocyte recruitment.     
Zusammenfassung 
Auf Nanotechnologien basierende Methoden spielen eine zunehmende Rolle in der 
biomedizinischen Forschung. Quantum dots (QDs) sind eine Gruppe künstlich 
hergestellter Nanopartikel mit speziellen Fluoreszenzeigenschaften, die im Rahmen 
zahlreicher bildgebender Verfahren eingesetzt werden können. Die Substitution der 
Partikeloberflächen mit definierten molekularen Strukturen könnte den Einsatz als 
zielgerichtete Kontrastsubstanzen oder Therapeutika im Hinblick auf eine Vielzahl 
klinischer Anwendungen ermöglichen. Unklar hingegen bleiben derzeit für den 
klinischen Einsatz wichtige Aspekte, wie etwa das prinzipielle oberflächenabhängige 
Verhalten von unspezifisch oberflächenmodifizierten, nicht auf distinkte molekulare 
Ziele ausgerichteten QDs im Organismus sowie mögliche gesundheitliche Folgen, die 
nach einer systemischen Applikation auftreten können. So liegen möglicherweise den 
durch gewisse Nanopartikel in epidemiologischen und experimentellen Studien 
beobachteten kardiovaskulären Pathologien unter anderem akute inflammatorische 
Effekte zugrunde, welche oftmals auf der Ebene der Mikrozirkulation initiiert werden. 
Die meisten in vitro Studien zeigen, dass insbesondere die Oberflächenstrukturen von 
QDs und anderen Nanopartikeln für unterschiedlich zytotoxische Effekte sowie ein 
variables Potential zur Freisetzung proinflammatorischer Zytokine verantwortlich zu sein 
scheint. Systematische in vivo Untersuchungen zu oberflächenabhängigen 
Wechselwirkungen systemisch applizierter QDs und proinflammatorischer Effekten auf 
Ebene der Mikrozirkulation und deren Bedeutung für biokinetische Größen liegen derzeit 
nicht vor. Die Ziele der vorliegenden Arbeit waren daher i) das Auftreten und die 
Bedeutung oberflächenabhängiger mikrovaskulärer Interaktionen von QDs und deren 
Beeinflussung biokinetischer Größen zu analysieren und ii) immunmodulatorische 
Effekte auf einzelne Schritte des mehrstufigen Prozesses der Leukozytenrekrutierung in 
vivo zu untersuchen. Hierzu wurden drei Typen kommerziell erhältlicher QDs mit jeweils 
unterschiedlichen Oberflächenmodifikationen (carboxylQDs, amine- und 
Polyethylenglykol-QDs (amine-QDs) und Polyethylenglykol-QDs (PEG-QDs) 
verwendet. Die physikochemische Charakterisierung der QD-Spezies erfolgte über die 
Analysetechniken der dynamische Lichtstreuung (DLS) sowie der mikroskalaren 
Thermopherese. In einer ersten Versuchsreihe wurden die Halbwertszeit im peripheren 
Blut, die Gewebeakkumulation in verschiedenen Organen sowie die hepatische und renale 
Ausscheidung quantifiziert. Ex vivo wurde die Verteilung der QD-Typen  in 
 verschiedenen Gewebeproben durch transmissionselektronenmikroskopische (TEM) 
sowie 2-photonenmikroskopische Aufnahmen untersucht. Durch eine Kombination aus 
reflected-light oblique transillumination (RLOT)- und Fluoreszenz-Intravitalmikroskopie 
am murinen M. cremaster wurden in unterschiedlichen Versuchsansätzen die 
Interaktionen von QDs mit Komponenten der Mikrozirkulation sowie leukozytäre 
Migrationsparameter visualisiert und quantifiziert. Die extrem kurze Verweildauer von 
anionischen carboxyl-QDs in der systemischen Zirkulation stand mit einer ausgeprägten 
Clearance durch das mononukleäre Phagozytensystem in Zusammenhang. Darüber 
hinaus konnte in weiteren Untersuchungen erstmalig gezeigt werden, dass das 
kontinuierliche Endothel kapillärer Netzwerke in Skelett- und Herzmuskelgewebe die 
Kapazität zur direkten Aufnahme zirkulierender carboxyl-QDs in Form Caveolae-
vermittelter Endozytose besitzt. Am präparierten aber nicht am nativen M. cremaster 
führte die Applikation von carboxylQDs zu deren Anreicherung in perivaskulären 
Makrophagen und einer signifikanten Zunahme adhärenter sowie (subsequent) 
transmigrierter Leukozyten. Weitere Versuchsreihen legen eine wahrscheinliche 
Beteiligung von Mastzellen an der intercellular adhesion molecule-1 (ICAM-1)- und 
endothelialen (E)-Selektinvermittelten Modulation der Leukozytenrekrutierung nahe. 
Höchstwahrscheinlich wird dieser Prozess durch die Endozytose der carboxyl-QDs durch 
perivaskuläre Makrophagen initiiert. Vermutlich ist die primäre Aktivierung 
perivaskulärer gewebeständiger Makrophagen eine Konsequenz der 
präparationsbedingten Gewebeschädigung des M. cremaster. Dies scheint eine 
Voraussetzung für die endozytotische Aufnahme der carboxyl-QDs zu sein, woraufhin 
Endothel- und Mastzellen sekundär infolge parakriner Mechanismen aktiviert werden, 
was eine gesteigerte Leukozytenrekrutierung zur Folge hat.   
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I. INTRODUCTION  
1. Background  
The physicochemical properties of any given material may undergo quantitative as well 
as qualitative changes in a nonlinear fashion when a certain reduction in volume 
expansion is reached [1]. Despite advantages nanoparticulate substances can entail, 
concerns arose regarding the yet fragmentary understood behavior and potential toxicity 
within an environmental, therapeutic/diagnostic or occupational context [2-4]. Amongst 
other engineered nanoparticles, the classes of semiconductor quantum dot (QD) 
nanocrystals have attracted high scientific interest in multiple areas of basic as well as 
clinically oriented biomedical research [5].  
  
Figure 1 Illustrative overview of the chemistry of core-shell QDs  
Coatings for aqueous solubility are as follows: (i) amphiphilic polymer coating with carboxyl(ate) groups; (ii) amphiphilic polymer 
coating with PEG oligomers; (iii) dithiol ligand with a distal PEG oligomer; (iv) dithiol ligand with a distal zwitterionic functionality; 
and (v) dithiol ligand with a distal carboxyl(ate) group. Common R groups include carboxyl, amine, and methoxy, although many 
others can be introduced (e.g., see vi, x, xi). Methods for conjugating biomolecules of interest (BOI) are as follows: (vi) biotin-
streptavidin binding; (vii) polyhistidine self-assembly to the inorganic shell of the QD; (viii) amide coupling using EDC/s-NHS 
activation; (ix) heterobifunctional crosslinking using succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC; 
structure not shown); (x) aniline-catalyzed hydrazone ligation; and (xi) strain-promoted azide–alkyne cycloaddition. The double 
arrows are intended to represent conjugation between the functional groups and, in principle, their interchangeability (not reaction 
mechanisms or reversibility). Not drawn to scale. Figure and appending caption directly adapted from Petryayeva et al. [6].  
  
Prototypic QDs consist of a semiconductor nanocrystaline metalloid core structure in the 
size range of 1 to 10 nm which is capped by an additional semiconductor shell. The 
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wavelengths of emitted photons are a direct function of the nanoparticle size [7]. QDs 
display wide absorption and narrow size-tunable emission spectra, considerably high 
quantum yield and fluorescence values, pronounced photostability [8] and are 
significantly more resistant to photobleaching and chemical degradation [9] than 
conventional fluorescent dyes [10]. Target-oriented biological activation is enabled by 
modifying the particle surface. Additionally decorating the particle surface with basic 
functional chemical groups can enhance the solubility in aqueous media [11] and is the 
precondition for further linkage with selective bioactive molecules [12]. The broad use of 
QDs as fluorescent probes for biomedical applications in in vivo imaging derives from 
their superior optophysical performance for deep-tissue imaging compared to classic 
fluorophores [13, 14]. Abundant biological components strongly interfere with 
conventional fluorescence imaging by producing tissue autofluorescence, light absorption 
and light scattering, thereby impairing resolution, signal intensity, and the optical depth 
of penetration [15]. By the utilization of near-infrared emitting QDs, autofluorescence 
phenomena can be minimized and allow high signal-to-background [16]. A growing body 
of in vitro data suggests that unspecific low-molecular surface modifications alone can 
facilitate the activation of otherwise specific receptor-mediated pathways upon cellular 
contact in vivo. It is not always predictable how much of the particle-surface is still 
accessible to inadvertently occurring molecular interactions, even if the secondary 
targeting substance has been linked to the particle-surface. Under circumstances of 
insufficient conjugation or rapid degradation of the secondary targeting substance upon 
cellular ingestion and endolysosomal processing, QDs could exert unwanted or even 
adverse effects [17]. Nanoparticles immediately adsorb proteins in biological media, 
thereby forming a dynamic protein corona: a dynamic function of physicochemical 
particle characteristics and the surrounding biological environment [18]. However, when 
QDs are used as vascular contrast agents or for labeling of biological structures for in vivo 
imaging, they usually need to be directly injected into the blood stream [19-21]. The 
systemic administration of QDs for various purposes in a biomedical context inevitably 
subjects the vascular compartment with an initially high fraction of the applied dose [22]. 
Since the large internal surface area of the vascular system is mainly provided by the 
endothelial lining of the microcirculation, circulating QDs are particularly likely to 
interact with components of microvascular networks. As inflammatory reactions may play 
a central role in many nanoparticle-elicited cardiovascular effects observed after 
occupational or experimental exposure and given the fact that inflammatory reactions are 
often triggered on the level of the microcirculation [23], microvessels themselves are 
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eventually a critical anatomical location at which circulating or accumulated nanoparticles 
exert (adverse) biological responses [24].  
2. Results and discussion  
2.1. Physicochemical characterization and protein binding of QDs  
Three types of commercially available QDs with a differently functionalized surface 
coating (Qdot® ITK™ carboxyl, Qdot® ITK™ amine (PEG), and Qdot® ITK™ 
nontargeted (PEG) (655 nm fluorescence peak emission) were chosen. The three subtypes 
investigated have an identical nuclear composition, a CdSe core ensheathed by an inner 
layer of ZnS. The outer layer and hence the particle-surface is provided by the respective 
chemical surface modification linked to the ZnS shell. According to the manufacturer, the 
QDs used in our studies all share an identical ellipsoid inorganic core with diameters of 6 
nm (minor axis) by 12 nm (major axis) [25]. Using DLS and microscale thermophoresis, 
hydrodynamic diameters, polydispersity indices, and zeta potentials of each QD species 
in different solutions were measured. DLS calculates the hydrodynamic diameter of a 
given particle in aqueous solution by correlating detected dynamic changes in light 
scattering as a result of Brownian particle motion. So, mean values of hydrodynamic 
parameter, hydrodynamic peak distribution values, and the polydispersity index of the 
respective particle in solution can be determined [26]. This method is regularly used for 
particle characterization of QDs in aqueous media [27-32]. On the other hand, some 
investigators have questioned the accuracy of DLS for determination of physicochemical 
parameters of QDs, as engineered constructs with different constituents could influence 
the data obtained [17, 33]. In addition to that, DLS routinely uses the Stokes-Einstein 
equation to determine the diffusion coefficient of a spherical particle in aqueous solution. 
As QDs used in this study had a more elliptical configuration, confirmed by high-
resolution transmission electron microscopy, the validity of this approximated formula on 
the accuracy of our measurements obtained by DLS was tested by additionally employing 
the method of Microscale Thermopheresis [34, 35]. This approach utilizes local mobility 
changes of QD concentrations in free solution upon the stimulation with an infra-red laser 
[35]. Hydrodynamic diameters measured with both methods are in good accordance with 
each other [28, 29]. The physicochemical values obtained here confirm the particle 
characterization measurements done by Zhang and Monteiro-Riviere, where QDs were 
scaled via size exclusion chromatography on high-performance liquid chromatography 
[17]. As a measure of unspecific protein binding affinity, hydrodynamic diameters of QDs 
were also assessed in protein-containing media (PBS + mouse serum) which approximate 
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the physiological environment QDs will encounter upon systemic administration. A gain 
in hydrodynamic diameter in mouse serum is interpreted to mirror the quantitative amount 
of protein adsorption on a particles’ surface. PEGylation has been repeatedly shown to 
significantly reduce the amount of unspecific protein binding [36]. As expected, PEGQDs 
showed the lowest increase in hydrodynamic diameter.  Carboxyl-QDs displayed the 
highest tendency to bind serum proteins. This also resulted in a reduction of absolute zeta 
potential negativity, possibly a consequence of protein shielding. Although the zeta 
potential, a “(…) measurable quantity used to control the intensity of the repulsive 
electrostatic interaction between the charged colloidal particles (…)” [37] is also related 
to the actual surface charge, those terms are not synonymous. This, as well as the fact that 
the effective number of terminal located positively charged amino-groups on amine-QDs 
might be reduced due to PEG-chain-entanglement, as hypothesized by Kelf et al. [38] can 
explain the moderately negative zeta potential values of amine QDs, similar to those of 
PEG-QDs. Quantitative and qualitative characteristics of the socalled protein corona built 
up around nanoparticles in biological media are thought to be chiefly involved in 
mediating particle behavior and biological impact [39].   
2.2 Semiquantitative assessment of organ distribution and blood kinetics  
Semiquantitative assessment of organ distribution and blood kinetics was done by 
establishing calibration curves with different concentrations of QDs. Solid tissue samples 
were solubilized and calibration curves were established for each tissue type as previously 
described by Robe et al. [40] with minor adaptions. Both organ distribution and blood 
kinetics were analyzed by relating the fluorescence intensity value measured in the 
respective sample to the corresponding calibration curve established earlier. PEGQDs had 
a considerably long circulating half-life of 513.4 ± 152.1 min upon systemic application. 
Many studies have shown that PEG exhibits a stealth effect as it shields the decorated 
material from opsonization. So, the typically observed rapid clearance of circulating 
nanoparticles via the mononuclear phagocytic system is circumvented and the blood half-
life significantly prolonged [41]. Accordingly, a lower overall tissue deposition profile 
was found compared to carboxyl- and amine-QDs. Carboxyl-QDs had a very low resident 
time in the circulation, the blood half-life was 5.8 ± 0.4 min. In an early imaging study by 
Ballou et al., the circulating half-life of carboxyl-modified 655 nm emitting QDs (QD655) 
was determined to be 4.6 ± 1.0 min [42]. The QDs were purchased from the same 
commercial provider and therefore identical to the carboxylQDs used in our studies. 
Amine QDs in our study exhibited a mean residence time in the circulation of 29.0 ± 2.8 
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min. The semiquantitative measurements of QD bloodkinetics were comparable to the 
real-time decay of QDs fluorescence out of the cremasteric vascular system observed by 
in vivo fluorescence microscopy. The blood kinetics of QDs were determined by the 
analysis of consecutively obtained blood samples applying a fluorescence-based imaging 
system. Organ distribution of QDs was analyzed after perfusion with ice-cold ringer 
solution by inserting a catheter in the jugular vein to wash out the remaining blood in the 
organ vascular system. The remaining blood pool within an extracted organ adulterates 
the quantitative value of organ-specific accumulation expressed as percentage of the 
injected dose (% ID)/g tissue. This could lead to a substantial overestimation of the actual 
tissue-specific deposition [43]. On the other hand, Su and Sun have pointed out that 
rheological effects of systemic perfusion could also wash out QDs residing in the 
extravascular space or those being only loosely attached to cellular surfaces [44]. It 
suggests itself to exploit the QDs inherent fluorescence for quantification of their 
biokinetics. However, next to fluorescence-based quantification approaches, the 
biodistribution of QDs can be determined by coupling the particle with a radioactive 
tracing compound [45] or applying inductively coupled plasma-mass spectrometry (ICP-
MS) for element analysis. Fluorescence-based quantification techniques work on the 
assumption that the fluorescence intensity values measured are a direct function of the 
QD concentration. It has been argued that the validity may be weakened by the variability 
of background fluorescence in biological samples [46], compartment-derived 
fluorescence intensity changes, and fluorescence decay in the course of structural 
degradation or aggregation [47, 48]. We therefore cannot positively rule out that our 
fluorescence-based measurements of QD-concentrations in biological samples might be 
affected by e.g. fluorescence quenching due to unspecific surface defects or as a result 
from intracellular vesicular compartmentalization [49]. However, for the time being, there 
is no overwhelming evidence for substantial chemical in vivo dissolution of the 
customized QDs we used reported in the literature [50].   
2.3 Association of QDs with the capillary vascular endothelium  
Within the time course similar to the calculated half-life, the clearance of circulating 
carboxyl-QDs in the cremasteric microcirculation revealed that the endothelial lining of 
the capillary network remained continuously and exclusively fluorescent. CarboxylQDs 
were also weakly and more irregularly associated with the endothelial layer of 
postcapillary venules but practically absent in precapillary vessel segments. The first 
order clearance-kinetics of nanoparticles in the circulation are generally attributed to 
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either the mononuclear phagocyte system (phago-/endocytosis due to opsonization with 
serum proteins [51]) or renal filtration (relevant for nanoparticles with hydrodynamic 
diameters > 5.5 nm [52]). Lee and colleagues were probably the first to demonstrate a 
possible link between coating-dependent differences in the biodistribution of QDs and the 
occurrence of interactions with the vascular system in a more complex ex vivo tissue 
model. Neutral QDs decorated with polyethylene glycol (QD-PEG) or negative QDs 
decorated with carboxyl-groups (QD-COOH) with a hydrodynamic size of approximately 
40 nm were used [53]. Quantitative tissue deposition was assessed after intra-arterial 
infusion of QD-PEG or QD-COOH in media for 4 h at different concentrations (1.67, 3.33 
and 6.67 nM, respectively) into isolated perfused porcine skin flaps  harvested from 
Weanling Yorkshire pigs, followed by a 4-h wash-out phase (perfusion with media 
solely). QDs were quantified in arterial and venous media via fluorescence intensity as 
well as ICP-MS. Frozen skin flap sections were prepared for confocal microscopy and 
hematoxylin/eosin staining. The differences in arterial-venous fluorescence values for 
QD-COOH were significantly higher than those obtained for QD-PEG, indicating a 
stronger tissue deposition of QD-COOH. Confocal microscopy analysis of frozen tissue 
sections further showed that QD-COOH accumulated in the capillaries of the skin [54]. 
The occurrence of capillary endothelial cell-mediated clearance of carboxyl-QDs from 
the circulation in our experiments has also been verified in the myocardium and skeletal 
muscle tissue of the abdominal wall by ex vivo 2-photon microscopy.   
2.4 In vitro uptake of QDs  
Confocal microscopy and flow cytometry analysis of cultured human microvascular 
endothelial cells exposed to carboxyl-QDs show a high amount of endocytotic uptake and 
intracellular accumulation in terms of vesicular storage. The endothelial layer of the 
human cardiovascular system is estimated to cover a total luminal surface area of 
approximately 350 m2 [55]. Although the entirety of endothelial cells builds up a coherent 
epithelial monolayer, this cellular population is not homogeneous but shows considerable 
adaptive differences by means of morphology and functional features. The anatomical 
location within the vascular tree determines dissimilar and eventually changing 
rheological parameters, the composition of subintimal tissues, exposure towards signaling 
factors, nutrients, and many more micro-environmental differences significantly 
influencing the endothelial cellular phenotype [56]. TEM confirmed that carboxyl-QDs 
were internalized into capillary endothelial cells by caveolae-mediated endocytosis. 
Caveolae are cellular invaginations which belong to the class of glycolipid raft membrane 
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domains defined by the co-localization with the protein caveolin-1 [57]. Endothelial cells 
of non-fenestrated continuous capillaries in lung, skeletal and heart muscle tissues show 
by far the highest density of caveolae [58]. Caveolae of continuous capillary endothelial 
cells are morphological and functional distinct microdomains implicated in a variety of 
endocytotic pathways. Caveolae-mediated receptor-dependent endocytosis of albumin 
[59], insulin [60], and α1-acidic glycoprotein [61] is a specific function of the continuous 
capillary network. Scavenger receptors (SRs) have been shown to concentrate within 
these specialized lipid-domains [62]. The human plasma proteome is presently reported 
to consist of 1929 different proteins [63] under which albumin is the most abundant 
protein. Since endothelial caveolae account for the specific receptor-mediated uptake 
and/or transcytosis of endogenous plasma proteins but also recognize intrinsic 
macromolecules with an altered structure, a possible relation between the pronounced 
adsorption of serum proteins to carboxyl-QDs or their intrinsic structural properties and 
their selective association with the capillary endothelium of skeletal and heart muscle 
tissue could exist. There is a limited amount of in vitro studies available which specifically 
provide mechanistic insights into principal modes of surface-related QDs cellular uptake. 
A number of limitations should be considered when the results obtained in vitro are 
transferred to an in vivo scenario. These include a great heterogeneity regarding QD 
synthesis, core structure, surface chemistry, dosage, cell lines, incubation time, and 
culture media. Zhang and Monteiro-Riviere specifically addressed the in vitro endocytosis 
of carboxyl-QDs (QD655-COOH) from the same commercial source and identical to 
those we used in our in experiments. QD655-COOH were rapidly internalized by cultured 
human epidermal keratinocytes within 5 min after application. The involvement of 
caevolin-1 and competitive binding with cholera toxin B indicated a lipid raft/caveolae-
mediated mechanism of endocytosis. The surfacedependent specificity of binding and 
internalization led the authors hypothesize that QD655-COOH nanocrystals initialize a 
receptor-mediated endocytotic pathway [17]. The effects exerted by the inhibitors of SRs, 
polyinosinic acid and fuicodan, argue for their role in QD655-COOH-mediated 
endocytosis. Interestingly, both low-density lipoprotein (LDL) and acetylated low-density 
lipoprotein (AcLDL) dose-dependently competed with QD655-COOH-mediated 
endocytosis in coincubation experiments. Thus, the authors conclude a combined 
mechanism of clathrin-independent receptormediated endocytosis involving a LDL 
receptor/SRBI-pathway [17]. In a study by Fujivara et al., the endocytosis of anionic 
liposomes by cultured macrophages was investigated. The involvement of SRs was 
proofed in cross-experiments in which preincubation with poly(acrylic acid) (PAA)-
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coated liposomes reduced the uptake of AcLDL, dextran sulfate as well as maleylated-
bovine serum albumin. Also LDL, being no specific ligand of SRs, partially inhibited 
PAA-liposome uptake [65]. In an in vitro study by Xiao et al. the uptake mechanisms of 
the very same three QD-species used in our studies were assessed in two human epithelial 
cell lines. Solely QD655-COOH but neither amine-PEG nor PEG-QDs were internalized 
after a 12 h incubation period. As QDs were recovered in lysosomes, the authors 
hypothesize a clathrin-dependent mode of internalization [66]. Different results were 
reported by the group around Al-Hajaj N. et al. who investigated the endocytosis of 
different semiconductor QDs. The cationic QDs showed a generally higher rate of cellular 
internalization as assessed by spectrofluorometric analysis. Despite ligand- and cell-
specific differences, lipid-raft mediated endocytosis was identified as the common 
mechanism of internalization [67]. In our own experiments, endocytosis of QDs by 
murine macrophages was analyzed 15 min after in vitro incubation. Confocal laser-
scanning microscopy showed that carboxylQDs were highly endocytosed and found in 
cytoplasmatic vesicles. Mean fluorescence intensity (MFI)-values were approximately 50 
times higher for macrophages challenged with carboxyl-QDs compared to those obtained 
for amine-QDs and PEG-QDs. Clift et al. also observed a principally more rapid 
internalization of carboxyl-modified QDs with a 565 nm (QD565) emission-spectrum in 
comparison to amine-modified QD565. However, co-localization of carboxyl-QDs with 
the early endosomal marker 1 was not noticed before 30 min of in vitro incubation [68]. 
This is comparatively slow when compared to our in vitro uptake rates but may be 
explained by strain differences and other culture conditions. Some SRs have been 
specifically localized to endothelial caveolae of microvascular networks. A high 
expression of both caveolin and CD36 in the murine lung, heart, and skeletal muscle-
tissue is reported. The majority of caveolinrich domains containing CD36 is provided by 
the capillary endothelial lining due to the large surface area occupied; especially in heart 
and muscle tissue, whereas the lung epithelial tissue, mainly consisting of type I 
pneumocytes, accounts for probably 50% of the total amount of lung caveolae [62]. Other 
(micro)vascular SRs include lectin-type oxidized LDL receptor-1 [69], SR-BI [70], 
receptor for advanced glycation endproducts [71], collectin placenta 1 [72], SR expressed 
by endothelial cells-I [73], fasciclin EGF (endothelial growth factor)-like, laminin-type 
EGF-like, and link domain-containing SR-1 (FEEL-1) and FEEL-2 [74].  
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2.5 Clearance of carboxyl-QDs by capillary endothelial cells  
In conclusion, our data can describe the capillary endothelial network of skeletal and heart 
muscle tissue as an arborescent nonphagocytic functional entity with the yet 
underestimated ability to reduce the systemic bioavailability and influence the tissue 
deposition of carboxyl-modified QDs in addition to the clearance via the mononuclear 
phagocyte system. The entirety of skeletal muscle tissue in mice and man averages 
approximately 45 % of the total body weight [75, 76]. In our study, we found that upon 
systemic injection of carboxyl-QDs, 2.4 ± 0.2 % ID/g tissue were recovered after 1 h in 
skeletal muscle tissue. At this point due to complete clearance, no more circulating 
carboxyl-QDs are detectable in the blood stream. An almost exclusive staining of the 
capillary endothelial network was detected. Ultrastructural analysis reveals a 
caveolaemediated endocytosis of carboxyl-QDs within the capillary networks of skeletal 
muscle. We therefore conclude that, next to the clearance by the mononuclear phagocytic 
system, the capillary endothelial lining of the murine skeletal muscle system has a 
significant impact on the biokinetics of carboxyl-QDs by means of active capillary 
retention of approximately 26 % of the applied dose.   
2.6 Modulation of leukocyte rolling in vivo by PEG- and carboxyl-QDs  
The leukocyte recruitment cascade is usually initiated by transient interactions between 
leukocyte and endothelial surfaces. Capture and subsequent rolling of leukocytes on the 
luminal surface of vascular endothelial cells are mediated by a family of three single 
chained carbohydrate-recognizing transmembrane glycoproteins, namely E-, platelet (P)-
, and lymphocyte (L)-selectin [77]. Overlapping as well as distinct functions of these C-
type lectins for leukocyte recruitment in vivo have been scrutinized over the last two 
decades. The expression of E-selectin is limited to endothelial cells and upregulated upon 
cytokine-induced endothelial activation [78]. P-selectin on the other hand is also 
expressed in resting endothelial cells where it is stored in Weibel-Palade bodies and 
rapidly translocated to the endothelial surface by fusion of P-selectin-containing storage 
vesicles with the cellular membrane after endothelial activation. In the mouse cremaster 
model, tissue exteriorization-induced early leukocyte rolling in postcapillary venules via 
P-selectin is a direct consequence of this process [79]. L-selectin is constitutively 
expressed on many leukocyte subsets, contributes to leukocyte recruitment during 
inflammation, and is critically involved in lymphocyte binding to high endothelial venules 
[80]. Leukocyte rolling flux fraction after dosing with carboxyl- or amine-QDs did not 
differ from vehicle-treated control animals but was significantly increased upon 
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application of PEG-QDs. In vivo fluorescence microscopy showed a discontinuous 
staining of postcapillary venules suggesting local clustering of PEG-QDs. Electron 
microscopy analysis revealed that PEG-QDs associate with amorphous, probably lipid 
containing structures adjacent to the luminal side of or in between microvascular 
endothelial cells. Next to reducing unspecific protein binding, this polymer also acts as a 
fusogen of biological membranes [81]. Given the rapid onset of the PEG-QD-elicited 
increase in leukocyte rolling flux fraction, it can be speculated that clusters of PEG-QDs 
may lead to distortions of the endothelial membrane structure, eventually promoting the 
fusion of intracellular vesicles and possibly Weibel-Palade bodies in close proximity to 
the luminal surface with the outer membrane, thereby increasing the amount of Pselectin 
on the endothelial surface. PEG-QDs do not further influence leukocyte adhesion and 
transmigration. It could also be the case that the extracellular PEGQD/lipid-clusters 
facilitate leukocyte rolling but impede the formation of firm molecular contacts between 
leukocytes and the actual endothelial surface. Although no changes in the number of 
rolling leukocytes in postcapillary venules were detected, a significant reduction of 
leukocyte rolling velocity was observed at 45 and 60 min after application of carboxyl-
QDs. Hence, intensified bidirectional signaling events can occur, thereby promoting 
further steps of leukocyte recruitment [82]. The involvement of E-selectin is mandatory 
for cytokine-induced slow leukocyte rolling in postcapillary venules in vivo [83].   
2.7 Engagement of E-selectin in modulation of leukocyte recruitment by carboxyl- 
QDs in vivo    
E-selectin exerts its functions via three glycoprotein-ligands expressed on neutrophils: P-
selectin glycoprotein-ligand 1, E-selectin ligand 1 and CD44 [84]. E-selectinmediated 
leukocyte-endothelial interactions functionally activate lymphocyte functionassociated 
antigen 1 (LFA-1), a ß2-integrin expressed on leukocytes, by converting the molecular 
structure towards an intermediate-affinity state facilitating binding to endothelial ICAM-
1. Thus, slow leukocyte rolling also involves LFA-1/ICAM-1 interactions. Interestingly, 
leukocyte rolling velocities on P-selectin in autoperfused flow chambers are comparable 
to those observed on E-selectin when ICAM-1 is added to P-selectin [85]. Also 
macrophage receptor-1 has been described to contribute to slow rolling by interacting 
with endothelial ICAM-1 [86]. E-selectin-promoted slow leukocyte rolling is typically 
characterized by rolling velocities ~5 µm/s [83] whereas P-selectin-dependent leukocyte 
rolling velocities are in the range of ~35 µm/s [87].  
However, rolling velocities ≤5 µm/s in the mouse cremaster assay are usually observed 
within at least two hours following the intrascrotal injection of proinflammatory cytokines 
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[83] since the expression of E-selectin is regulated on the transcriptional level requiring 
de novo synthesis. Therefore, the full amount of E-selectin engagement within the 60 min 
observation window in our studies is unlikely to be registered since the peak expression 
of E-selectin following endothelial activation has been shown to occur after ~6h [88, 89]. 
Nevertheless, the observed reduction in leukocyte rolling velocity as early as 45 min after 
injection of carboxyl-QDs seems to reflect an increasing availability of E-selectin on the 
postcapillary endothelial surface as a consequence of enhanced expression of E-selectin. 
This was confirmed by confocal immunofluorescence microscopy of E-selectin in 
postcapillary venules 60 min after application of carboxylQDs. The expression of E-
selectin is controlled by proinflammatory cytokines. Wellinvestigated cytokines which 
have been shown to exercise control on the endothelial expression of E-Selectin in a direct 
and/or intermediate fashion include tumor necrosis factor-alpha (TNF-α), interleukin-1 
beta (IL-1ß), lipopolysaccharide (LPS) [90], interleukin (IL)-6, interferon gamma [91], 
and macrophage inflammatory protein-2 (MIP-2) [92]. As the functional consequence, 
i.e. significant reduction in leukocyte rolling velocity upon systemic application of 
carboxyl-QDs was paralleled by a considerably fast upregulated expression of E-Selectin 
in postcapillary venules, it is likely to assume that a very rapid chemokine-driven mode 
of postcapillary endothelial activation precedes this event. Although proinflammatory 
cytokines themselves underlie transcriptional regulation, rapid endothelial activation can 
be achieved by the release of pre-synthesized cytokines which enables immediate 
transcellular communication.   
2.8 Preparation-induced activation of perivascular macrophages is necessary for the 
uptake of carboxyl-QDs and further events leading to a modulation of  
leukocyte recruitment in vivo  
Given the temporary dynamics observed, the immunomodulatory properties following the 
acute challenge of carboxyl-QDs in the microcirculation of the surgically exposed 
cremaster muscle most likely reflects a secondary endothelial activation in succession of 
the local liberation of pre-synthesized chemokines. The fact that no significant changes 
in leukocyte recruitment were noted when carboxyl-QDs were injected 60 min prior to 
surgical preparation of the cremaster muscle gives some important hints regarding the 
hypothetical pathways carboxyl-QDs might influence the leukocyte recruitment cascade. 
To begin with, the presence of carboxyl-QDs in the systemic circulation apparently does 
not seem to provoke an acute systemic inflammatory response at the dosage tested. This 
assumption is supported by the lack of quantitative alterations in leukocyte recruitment in 
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the cremaster muscle when surgical exposure was done at 60 min after systemic 
administration. No changes in white blood cell counts and no apparent signs of discomfort 
or illness were observed. Interestingly, dose- and chargedependent acute toxicity and 
prothrombotic effects of Catskill green, carboxyl- or amine-modified QDs (Type I 
EviTags) were observed in a study conducted by Geys et al. A dose-dependent potency 
to induce fibrin-rich thrombi in the pulmonary circulation was noted for both QD types, 
but more pronounced in the case of carboxyl-QDs [31]. In our experiments no obvious 
prothrombotic events were noticed, however, we did not assess this systematically. 
Moreover, no carboxyl-QDs were found in perivascular cells of the native cremaster 
muscle. Thus, the merely contact of circulating carboxyl-QDs with the postcapillary 
endothelium of the cremaster muscle does not seem to directly activate endothelial cells 
in the absence of preparation-induced tissue injury. A mild sterile inflammatory response 
to microsurgical tissue manipulation and exteriorization of the cremaster muscle is a well-
known model-inherent phenomenon. Sterile alterations of tissue integrity in the absence 
of pathogens or toxins etc. still lead to inflammatory reactions as a result from the 
endogenous release of different signals from cells experiencing stress, lesions, or necrosis 
[93]. Normally hidden endogenous molecules, which are liberated when the structural 
integrity of a tissue is destroyed and subsequently activate innate immunological 
responses, are termed “damage-associated molecular patterns” (DAMPs). The 
recognition of these normally sequestered DAMPs by corresponding receptors on innate 
immune cells leads to their activation and initiation of further inflammatory reactions 
[94]. In macrophages, the nucleotidebinding oligomerization domain (NOD)-like receptor 
family, pyrin domain containing 3  
(NLRP3) inflammasome reacts on a broad variety of “pathogen-associated molecular 
patterns” (PAMPS) and DAMPs and exerts important functions, also in sterile 
inflammation upon tissue injury. The full activation of the NLRP3 inflammasome 
obviously requires initial priming via pattern recognition receptor-signaling which seems 
to be a necessary step preceding the induction of complete activation [95]. 
Wellestablished DAMPs include extracellular nucleotides, extracellular heat shock 
proteins, extracellular high-mobility group protein B1, uric acid crystals, oxidative stress, 
laminin, S100 proteins, and hyaluronan [96]. With regard to immune effects of engineered 
nanoparticles, it has been observed that protein adsorption to nanoparticles can lead to 
conformational changes and subsequent exposure of cryptic epitopes. The hypothesis that 
the activation of pattern recognition receptors by DAMPs on tissueresident cells with 
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innate immunity function is required for activating perivascular macrophages to take up 
carboxyl-QDs is supported by the following: Intrascrotal application of LPS 2 h prior to 
systemic application of carboxyl-QDs caused a strong accumulation of carboxyl-QDs in 
perivascular cells independent of the surgical preparation. Vehicle-treated controls did not 
show an accumulation of carboxyl-QDs in perivascular cells (Praetner and Rehberg, 
unpublished observations).   
2.9 Endocytosis of carboxyl-QDs by perivascular macrophages in vivo  
In vivo, MFI-values of regions of interest over perivascular macrophages visibly increased 
already 180 sec after systemic application of carboxyl-QDs in our study [29]. When 
antigen-presenting cells are stimulated in vitro towards an active state, this usually 
includes a more efficient endocytosis and might go along with a different morphology. 
For instance, Zhang et al. reported an increased uptake of QD655-COOH by dendritic 
cells after treatment with LPS. In vitro activated dendritic cells (derived from porcine 
monocytes matured in the presence of granulocyte-macrophage colonystimulating factor 
and IL-4 preferentially ingested carboxyl-QDs by rapid clathrindependent scavenger-
mediated endocytosis involving F-actin as well as phospholipase C [33]. Interestingly, 
Bateman et al. made a similar observation in an in vivo study where a model of 
endotoxemia increased the clearance of methoxy-PEGylated 5000MW QDs [97]. Liver 
sinusoidal fenestrated endothelium provides Kupffer cells and hepatocytes excellent 
opportunities to come into contact with circulating QDs. Also splenic macrophages, 
which are situated in an open circuit environment, are in a different activation state 
compared to macrophage populations in tissues which are normally shielded from the 
external surrounding [98]. In the case of skeletal muscle perivascular macrophages in our 
model, preparation-induced activation by DAMPs seems to be a prerequisite for the 
induction of a highly active endocytotic phenotype. In vitro activated dendritic cells 
preferentially ingest carboxyl-QDs by rapid clathrindependent scavenger-mediated 
endocytosis [33]. Vessel-lining macrophages have been reported to extend cytoplasmatic 
protrusion through endothelial and epithelial tissues [99]. Recently, perivascular CX3C 
chemokine receptor 1+-cells were shown to sample the luminal content of adjunct 
microvessels via a dendritic extension in vivo [100]. The basement membrane of the 
postcapillary endothelial cell lining is surrounded by a heterogeneous population of 
perivascular cells of the myeloid lineage, including cells which mediate innate immunity 
responses [101]. Particle uptake in our model probably leads to secretion of cytokines and 
parallel activation of mast cells and endothelial cells.   
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2.10 Nanoparticle-induced release of proinflammatory cytokines in vitro – insights  
from the literature  
Ryman-Rasmussen et al. analyzed the cellular uptake of commercially available QD 565 
and QD655 semiconductor nanocrystals with the identical three different surface 
functionalizations utilized in our studies. All types of QDs investigated were found inside 
primary human neonatal epidermal keratinocytes (HEK) 24 h after incubation. 
Carboxylic-acid-coated QDs of both sizes showed the highest degree of stained HEKs. 
TEM revealed that all QD-types were either found agglomerated within vesicular 
structures or free in the cytoplasm. The most pronounced cytotoxicity was found upon 
challenge with carboxylic-acid coated QDs. Carboxyl-acid coated QDs of both sizes also 
showed a significant release of IL-1ß. The IL-6 release was significantly higher for 
carboxylic-acid coated QD565 particles. A significant release of IL-8 was detected for 
carboxylic-acid coated QD565 particles. PEG-amine QDs of both sizes induced 
cytotoxicity 48 h after incubation (20 nM). Also, PEG-amine-QDs induced a significant 
increase in the release of IL-6 after incubation with 20 nM after 48 h. No change in the 
release of proinflammatory cytokines was detected in the case of PEG-QDs [25]. Adachi 
et al. showed that 20-nm but not 1000-nm particles induced a IL-1ß response which 
involved the adenosine triphosphate-binding P2X purinoceptor 7 [102]. In a study by 
Fischer et al, octadecylamine-modified poly(acrylic acid)-coated QDs caused an increase 
in TNFα levels, but not high enough to reach statistical significance [103]. Zhang Y. et 
al. observed that exposure to PAA-coated QDs in a macrophage cell line led to high 
concentrations of TNFα and IL-1ß after 24 h and activation of the nuclear factor kappa-
light-chain-enhancer of activated B cells-pathway [32]. Adherence, as the next step in the 
leukocyte recruitment cascade, is characterized by firm adhesion at the postcapillary 
endothelium, mediated by the interaction of leukocyte integrins and an endothelial 
receptor of the immunoglobulin superfamily [104]. ICAM-1 is a member of the 
immunoglobulin superfamily and constitutively expressed on postcapillary endothelial 
cells under physiologic conditions [105].  
2.11 ICAM-1 plays a functional role for carboxyl-QD-elicited modulation of  
leukocyte recruitment in vivo  
To further understand the mechanisms of carboxyl-QD elicited modulation of leukocyte 
recruitment, we used a specific anti-ICAM-1 monoclonal antibody (YN-1) in additional 
experiments. A significant reduction of adherent as well as transmigrated leukocytes in 
the YN-1-treated group was noted. These results suggest that ICAM-1 is a central 
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adhesion molecule for the carboxyl-QD evoked amplification of leukocyte recruitment in 
the cremaster muscle. Interestingly, Foy and Ley demonstrated a central role of ICAM-1 
for chemoattractant-induced acute leukocyte adhesion following perivenular 
microinjection to the unstimulated postcapillary endothelium [106]. It was shown that  
MIP-2-induced neutrophil recruitment is mediated by TNF-α from resident mast cells. 
Contrasting to TNF-α, the expression of E-selectin upon challenge with MIP-2 was 
increased in wild type mice but not in mast cell-deficient animals [92]. In a study by 
Kneilling et al., it was found that local tissue inflammation in a mouse model of T-
cellinduced and TNF-dependent delayed-type hypersensitivity reaction strictly requires a 
direct crosstalk between mast cell-derived TNF and TNF-receptor-expressing endothelial 
cells, subsequently leading to upregulation of adhesion molecules necessary for leukocyte 
recruitment such as E- and P-selectin, ICAM-1, and vascular cell adhesion molecule 1 
[107].  
2.12 Mast cells contribute to the carboxyl-QD-induced modulation of leukocyte 
recruitment in vivo  
Mast cells origin from a hematopoietic lineage and are characterized by the large number 
of densely packed cytoplasmatic granules containing a variety of preformed inflammatory 
mediators which are rapidly released upon activation. Mast cells are found in most tissues, 
often in close vicinity to epithelial or vascular structures. Mast cells are being increasingly 
recognized as central effectors and regulators of macrophage, dendritic, and endothelial 
cell function during inflammatory responses [108]. Apparently, mast cells distinguish 
themselves from other innate immunity cells in the way that they appear to be the main 
source of preformed TNF-α, which can therefore be immediately released upon 
corresponding activation [109]. Also, a rapid release of eicosanoid mediators adds to the 
fast acting mode of mast cells [110]. The anatomical distance between mast cells and 
venular basement membrane probably averages 10 µm as estimated by in vivo microscopy 
of the mouse cremaster muscle [111]. To investigate whether mast cells are involved in 
carboxyl-QD-evoked modulation of leukocyte recruitment, the effect of cromolyn-
pretreatment was assessed in an additional set of experiments. Cromolyn is a member of 
mast cell-stabilizing agents which are thought to prevent mast cell degranulation. 
However, the specificity of cromolyn to act solely on mast cells has recently been 
questioned [112]. Species-, tissue-, and model-inherent differences might influence the 
specificity of mast cellstabilizers.   
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II. CUMULATIVE THESIS  
1. The contribution of the capillary endothelium to blood clearance and 
tissue deposition of anionic quantum dots in vivo:   
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Table 2   
Tissue deposition and excretion of QDs  
  Time carboxyl-QDs amine-QDs PEG-QDs  
Organ          
Heart  1 h  1.7 ± 0.1  0.9 ± 0..5  0  
  4 h  1.5 ± 0.2 # *  0  0  
  24 h  0.9 ± 0.1 # *  0  0  
Lung  1 h  6.7± 0.4 # *  1.9 ± 0.1  4.8 ± 0.5  
  4 h  6.2 ± 0.9   *  2.3 ± 0.1 §  3.9 ± 0.3  
  24 h  3.6 ± 0.9   *  1-6 ± 0.1 §  2.8 ± 0.2  
Liver  1 h  19.0 ± 10.6  5.1 ± 1.4  5.5 ± 1.5  
  4 h  4.8 ± 2.3  8.4 ± 1.7  2.4 ± 0.5  
  24 h  16.4 ± 4.1 # *  7.4 ± 0.8  4.3 ± 2.2  
Spleen  1 h  18.0 ± 1.3 # *  1.8 ± 0.4 §  0.8 ± 0.2  
  4 h  16.2 ± 1.0 # *  3.6 ± 1.9  2.5 ± 0.6  
  24 h  17.4 ± 3.7 # *  2.9 ± 1.8  0.7 ± 0.1  
Kidney  1 h  8.5 ± 1.5  4.9 ± 0.2  10.6 ± 2.1  
  4 h  7.7 ± 2.4  5.6 ± 0.4  10.5 ± 1.5  
  24 h  4.1 ± 0.4  4.8 ± 0.2  5.9 ± 0.7  
Thoracic aorta  1 h  10.3 ± 2.6 # *  0.6 ± 0.8  1.6 ± 0.1  
  4 h  8.2 ± 0.5 # *  0..5 ± 0.8  2.3 ± 1.2  
  24 h  8.3 ± 1.3 # *  0 §  1.2 ± 0.2  
Skeletal muscle  1 h  2.4 ± 0.4  0  0  
  4 h  2.4 ± 0.2 # *  0  0  
  24 h  1.9 ± 0.2 # *  0  0  
Thymus gland  1 h  2.2 ± 1.5  2.8 ± 1.1  0  
  4 h  2.0 ± 0.3 *  1.7 ± 0.1 §  0  
  24 h  1.4 ± 0.5 *  1.4 ± 0.1 §  0  
Lymph nodes  1 h  3.1 ± 0.9  2.7 ± 0.9  0.7 ± 0.1  
  4 h  3.6 ± 0.9 *  5.4 ± 1.0 §  1.2 ± 0.2  
  24 h  2.6 ± 0.6 # *  8.3 ± 1.5 §  0.8 ± 0.2  
Brain  1 h  1.0 ± 0.1 # *  0  0  
  4 h  0.7 ± 0.2 # *  0  0  
  24 h  0.7 ± 0.3 # *  0  0  
28 
Excreta 
Bile 1 h 15.7 ± 9.0 19.0 ± 7.8 6.1 ± 2.6 
4 h 18.5 ± 10.4 13.0 ± 2.7 6.2 ± 1.1 
24 h 1.4 ± 0.3 # * 13.1 ± 8.2 6.4 ± 3.1 
Duodenal Content 1 h  2.3 ± 0.6 3.2 ± 1.8 7.9 ± 3.5 
4 h  5.0 ± 2.0 2.7 ± 1.0 3.1 ± 0.9 
24 h 1.3 ± 0.7 3.2 ± 0.5 2.1 ± 0.5 
Faeces  1 h 11.2 ± 2.4 * 2.5 ± 0.9 §  13.7 ± 3.1 
4 h 7.6 ± 4.1 3.8 ± 1.4  10.4 ± 2.7 
24 h 16.1 ± 4.3 * 3.3 ± 2.3 §  15.9 ± 1.3 
Urine  1h  0 0 0 
4h  1.0 ± 0.2 0 1,0 ± 1.2 
24h 2.6 ± 0.4 2.3 ± 2.1 1.9 ± 0.3 
QDs were given intra-arterially (3 pmol/g body weight) into anesthetized male C57BL/6 mice (n = 5 per group; 
control mice received vehicle). To assess blood and tissue kinetics, fluorescence was quantitatively measured in 
blood and tissue samples at subsequent time points. Mean values of 4-5 experiments ± SEM are given (#, p<0.05 
[carboxyl-QDs vs PEG-QDs], *, p<0.05 [carboxyl-QDs vs amine-QDs], §, p<0.05 [amine-QDs vs PEG-QDs]). Zero 
(0) denotes values below detection limit (< 0.5 % ID/g tissue).  
Supplementary movie file:   
http://www.sciencedirect.com/science/article/pii/S0142961210006885 
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2. Quantum dots modify leukocyte recruitment depending on their surface
modification: 
30 
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Figure S1. QD localization in RAW264.7 murine macrophage cells   
Confocal fluorescence microscopy revealed localization of carboxyl-QDs (A, B), amineQDs 
(C, D), and PEG-QDs (E, F) in RAW264.7 macrophages 15 min after incubation with  
8 nM QDs. Z-stacks covering complete cells were projected. QD fluorescence is depicted in 
(A), (C), and (E) and merged with the corresponding bright field images in (B), (D) and (F). 
Fluorescence intensities are not directly comparable since PMT gain was reduced during 
image acquisition to avoid pixel oversaturation in case of carboxyl-QD. Scale bar: 30 μm  
  
  
  
Figure S2. Electron microscopic examination of QD localization in postcapillary venules   
Transmission electron microscopy was performed on ultrathin cross sections of cremasteric 
tissue 60 minutes upon application of QDs. Contrast of the tissue results from post-fixation 
of lipids with OsO4 only, representative images are shown. (A) Carboxyl-QDs were detected 
in perivascular macrophages (outlined in B, marked by arrow) in close vicinity to a blood 
49 
vessel embedded between muscle fibres. QDs are not visible at this magnification. Scale bar: 
A = 5 μm, B = 1 μm Supplemental movie files:  
http://pubs.acs.org/doi/suppl/10.1021/nl102100m/suppl file/nl102100m si 005.avi 
http://pubs.acs.org/doi/suppl/10.1021/nl102100m/suppl file/nl102100m si 006.avi 
http://pubs.acs.org/doi/suppl/10.1021/nl102100m/suppl file/nl102100m si 007.avi 
http://pubs.acs.org/doi/suppl/10.1021/nl102100m/suppl file/nl102100m si 008.avi 
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